Regenative Labs Highlights Advancements in Post-Surgical Breast Reduction
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
A clinical trial involving 828 patients found that three weeks of radiation following mastectomy did not increase reconstruction complications compared with the standard five-week course.